Research and experimental development on natural sciences and engineering
AURA BIOPHARM AS
Operating profit
NOK −135,000
Equity
NOK −885,000
Incorporated
2016
Share capital
NOK 300,000
Key figures · 2024
Current ratio
1.46
Equity ratio
-2177.4%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -332.2% | |
| Likviditet | ||
| Current ratio | 1.46 | |
| Working capital | 13k | |
| Soliditet | ||
| Equity ratio (%%) | -2177.4% | |
| Debt-to-equity ratio | -1.05 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.